Search Results - "Yoshioka, Manabu"

Refine Results
  1. 1

    Diagnostic Tools and Biomarkers for Severe Drug Eruptions by Yoshioka, Manabu, Sawada, Yu, Nakamura, Motonobu

    “…In accordance with the development of human technology, various medications have been speedily developed in the current decade. While they have beneficial…”
    Get full text
    Journal Article
  2. 2

    High S100A2 expression in keratinocytes in patients with drug eruption by Yoshioka, Manabu, Sawada, Yu, Saito-Sasaki, Natsuko, Yoshioka, Haruna, Hama, Kayo, Omoto, Daisuke, Ohmori, Shun, Okada, Etsuko, Nakamura, Motonobu

    Published in Scientific reports (09-03-2021)
    “…Telaprevir used as a protease inhibitor against hepatitis C virus is frequently associated with cutaneous adverse reactions. To explore a histological…”
    Get full text
    Journal Article
  3. 3

    Prediction of the invasive level of basal cell carcinomas in the facial area: Analysis of 718 Japanese cases by Matsushita, Shigeto, Nakamura, Yasuhiro, Tanaka, Ryota, Araki, Ryuichiro, Yamamura, Kentaro, Yoshioka, Manabu, Inoue, Akiha, Komori, Takaya, Saito, Shintaro, Teramoto, Yukiko, Nakamura, Yoshiyuki, Fujisawa, Yasuhiro, Aoki, Megumi

    Published in Journal of dermatological science (01-09-2020)
    “…•Predictors of the invasion level of basal cell carcinomas (BCCs) are unclear.•Tumor thickness showed a significant correlation with tumor diameter.•Invasion…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Development of a new grip for use with a long cane for visually impaired children by Shimizu, Junichi, Yoshioka, Manabu, Yonetsu, Ryo, Nakao, Hiroki, Kizaki, Hideomi

    “…Statement of context A new grip part for the long cane used by visually impaired children was developed and the effect of this grip, using the muscle activity…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Leptin controls hair follicle cycling by Watabe, Reiko, Yamaguchi, Takashi, Kabashima-Kubo, Rieko, Yoshioka, Manabu, Nishio, Daisuke, Nakamura, Motonobu

    Published in Experimental dermatology (01-04-2014)
    “…Leptin is a cytokine well known for its ability to control body weight and energy metabolism. Several lines of evidence have recently revealed that leptin also…”
    Get full text
    Journal Article
  11. 11

    Malignant Melanoma of the Nipple: A Case Report by Nagata, Yoshika, Yoshioka, Manabu, Uramoto, Hidetaka, Tsurudome, Yosuke, Yamada, Sohsuke, Hanagiri, Takeshi, Tanaka, Fumihiro

    Published in Journal of breast cancer (01-03-2018)
    “…Malignant melanoma rarely originates from the female nipple. Tumors that develop on the skin of the breast are often subject to a delayed diagnosis. Cytologic…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Profile fluctuation of peripheral blood in advanced melanoma patients treated with nivolumab by Saito, Ryuichi, Sawada, Yu, Saito‐Sasaki, Natsuko, Yamamoto, Kayo, Yoshioka, Haruna, Ohmori, Shun, Yoshioka, Manabu, Okada, Etsuko, Nakamura, Motonobu

    Published in Journal of dermatology (01-12-2018)
    “…Melanoma is a malignant tumor of the melanocytes with an unfavorable clinical behavior. Nivolumab, a representative anti‐programmed death 1 (PD‐1) antibody,…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A Retrospective Study of Superficial Type Atypical Lipomatous Tumor by Mashima, Emi, Sawada, Yu, Saito-Sasaki, Natsuko, Yamamoto, Kayo, Ohmori, Shun, Omoto, Daisuke, Yoshioka, Haruna, Yoshioka, Manabu, Okada, Etsuko, Aoki, Takatoshi, Hisaoka, Masanori, Nakamura, Motonobu

    Published in Frontiers in medicine (17-12-2020)
    “…Atypical lipomatous tumor (ALT) has been defined as a well-differentiated liposarcoma exhibiting a higher frequency of a local recurrence after surgical…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Nivolumab in the treatment of malignant melanoma: review of the literature by Mashima, Emi, Inoue, Akiha, Sakuragi, Yumiko, Yamaguchi, Takashi, Sasaki, Natsuko, Hara, Yoko, Omoto, Daisuke, Ohmori, Shun, Haruyama, Sanehito, Sawada, Yu, Yoshioka, Manabu, Nishio, Daisuke, Nakamura, Motonobu

    Published in OncoTargets and therapy (01-01-2015)
    “…Nivolumab was developed as a monoclonal antibody against programmed death receptor-1, an immune checkpoint inhibitor which negatively regulates T-cell…”
    Get full text
    Journal Article
  19. 19
  20. 20